Memantine as treatment for compulsivity in child and adolescent psychiatry: Descriptive findings from an incompleted randomized, double-blind, placebo-controlled trial

BACKGROUND: Autism spectrum disorder (ASD) and obsessive-compulsive disorder (OCD) are mental disorders with a considerable overlap in terms of their defining symptoms. The glutamatergic agent memantine appears to be a promising candidate for the treatment of ASD and OCD in children and adolescents....

Descripción completa

Detalles Bibliográficos
Autores principales: Niemeyer, Larissa, Mechler, Konstantin, Dittmann, Ralf W., Banaschewski, Tobias, Buitelaar, Jan, Durston, Sarah, Häge, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450066/
https://www.ncbi.nlm.nih.gov/pubmed/36092975
http://dx.doi.org/10.1016/j.conctc.2022.100982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450066/
https://www.ncbi.nlm.nih.gov/pubmed/36092975
http://dx.doi.org/10.1016/j.conctc.2022.100982

Ejemplares similares